Elevated IL-10 is Linked With the Expansion of T-bethighCD21low B Cells in Patients With Common Variable Immunodeficiency.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Elevated IL-10 is Linked With the Expansion of T-bethighCD21low B Cells in Patients With Common Variable Immunodeficiency.
Συγγραφείς: Cousin V; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Schaenzlestrasse 1, 79104, Freiburg, Germany.; Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany., Graumann A; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Geiger V; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Schaenzlestrasse 1, 79104, Freiburg, Germany., Sökler D; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bez P; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Medicine (DIMED), University of Padova, Padua, Italy., Gutenberger S; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Glaser C; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Andrieux G; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between, DKFZ and Medical Center - University of Freiburg, Freiburg, Germany., Frye BC; Clinic for Pneumology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany., Zissel G; Clinic for Pneumology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany., Calvillo CL; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916, Barcelona, Spain., Rodriguez-Ubreva J; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916, Barcelona, Spain., Ballestar E; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08916, Barcelona, Spain.; Epigenetics in Inflammatory and Metabolic Diseases Laboratory, Health Science Center (HSC), East China Normal University (ECNU), Shanghai, China., Hauck F; Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität (LMU), Munich, Germany., Voll RE; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Chevalier N; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Keller B; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Warnatz K; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. klaus.warnatz@uniklinik-freiburg.de.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. klaus.warnatz@uniklinik-freiburg.de.
Πηγή: Journal of clinical immunology [J Clin Immunol] 2026 Aug 15; Vol. 46 (1). Date of Electronic Publication: 2026 Aug 15.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE
Imprint Name(s): Publication: Amsterdam : Springer
Original Publication: New York : Plenum, c1981-
Ιατρικοί όροι (MeSH): Interleukin-10*/blood , Interleukin-10*/metabolism , Common Variable Immunodeficiency*/immunology , Common Variable Immunodeficiency*/metabolism , B-Lymphocytes*/immunology , B-Lymphocytes*/metabolism, Receptors, Complement 3d/metabolism ; Cell Differentiation/immunology ; STAT3 Transcription Factor/metabolism ; Interleukins/metabolism ; Lymphocyte Activation/immunology ; B-Lymphocyte Subsets/immunology ; Humans ; Female ; Male ; Interleukin-21 ; Signal Transduction ; Adult
Περίληψη: Common variable immunodeficiency (CVID) is frequently complicated by autoimmune and inflammatory manifestations associated with profound immune dysregulation (CVIDc), including expansion of T-bethighCD21low B cells (CD21low B cells). Elevated serum IL-10 levels have repeatedly been reported in CVIDc, yet their relationship to CD21low B-cell differentiation remains unclear. In this study, we determined a significant correlation between increased serum IL-10 levels and frequency of circulating CD21low B cells, particularly marked in CVIDc patients. Transcriptomic and protein analyses identified multiple cellular sources of IL-10 in CVID, including monocytes, T cells, and a subset of CD21low B cells in peripheral blood and inflamed tissues. CD21low B cells expressed elevated levels of IL-10 receptor subunits and displayed intact IL-10-induced STAT3 signaling, indicating preserved responsiveness to IL-10. Functionally, IL-10 alone neither induced CD21low B-cell differentiation nor inhibited IFN-γ-driven polarization. However, in vitro differentiation assays showed that IL-10 can substitute for IL-21 during CD40L/T cell-dependent differentiation of CD21low-like B cells and promote their survival in vitro. These findings suggest that IL-10 may support the expansion and persistence of CD21low B cells at inflammatory sites. Collectively, our data identify IL-10 as a component of the inflammatory environment associated with CD21low B-cell expansion and suggest that IL-10 can functionally replace IL-21 during their differentiation and promote their survival in CVID-associated immune dysregulation.
(© 2026. The Author(s).)
Competing Interests: Declarations. Conflicts of interest: The authors declare no conflicts of interests.
References: Front Immunol. 2025 Feb 12;16:1512279. (PMID: 40013136)
J Allergy Clin Immunol Glob. 2025 Apr 23;4(3):100488. (PMID: 40497017)
Eur J Immunol. 2014 Jun;44(6):1615-21. (PMID: 24643722)
Blood. 2008 Jan 1;111(1):77-85. (PMID: 17898316)
J Exp Med. 2009 May 11;206(5):1009-17. (PMID: 19414553)
Clin Immunol. 2004 Nov;113(2):161-71. (PMID: 15451473)
J Immunol. 2007 Mar 15;178(6):3932-43. (PMID: 17339494)
J Immunol. 2003 Nov 15;171(10):5034-41. (PMID: 14607900)
J Allergy Clin Immunol. 2020 Oct;146(4):912-915.e13. (PMID: 32169377)
Immunity. 2026 Feb 10;59(2):354-371.e9. (PMID: 41619728)
Arthritis Res Ther. 2024 Jan 15;26(1):23. (PMID: 38225658)
Front Immunol. 2020 Oct 21;11:535784. (PMID: 33193306)
J Clin Immunol. 2014 Nov;34(8):971-8. (PMID: 25246148)
J Clin Immunol. 2014 Jul;34(5):524-43. (PMID: 24827633)
Nat Rev Immunol. 2010 Mar;10(3):170-81. (PMID: 20154735)
Front Immunol. 2021 Feb 05;11:616832. (PMID: 33613543)
J Clin Immunol. 2014 Aug;34(6):615-26. (PMID: 24789743)
Scand J Immunol. 1999 Aug;50(2):215-22. (PMID: 10447928)
Bioinformatics. 2014 Aug 1;30(15):2114-20. (PMID: 24695404)
Cytokine. 2015 Jul;74(1):27-34. (PMID: 25481648)
Curr Opin Immunol. 2023 Jun;82:102300. (PMID: 36931129)
Nat Commun. 2024 Nov 28;15(1):10344. (PMID: 39609471)
Cells. 2022 Jan 28;11(3):. (PMID: 35159274)
J Leukoc Biol. 2001 Oct;70(4):624-32. (PMID: 11590200)
Nucleic Acids Res. 2015 Apr 20;43(7):e47. (PMID: 25605792)
J Allergy Clin Immunol. 2026 Feb;157(2):454-469. (PMID: 41176068)
Sci Immunol. 2021 Oct 15;6(64):eabh0891. (PMID: 34623902)
Blood. 2012 Feb 16;119(7):1650-7. (PMID: 22180439)
J Allergy Clin Immunol. 2026 Mar;157(3):754-766. (PMID: 41314478)
BMC Bioinformatics. 2009 May 27;10:161. (PMID: 19473525)
Front Immunol. 2023 Sep 28;14:1257398. (PMID: 37841257)
J Allergy Clin Immunol. 2018 Feb;141(2):730-740. (PMID: 28554560)
Cureus. 2024 Jul 5;16(7):e63875. (PMID: 39099913)
J Clin Immunol. 2023 Feb;43(2):371-390. (PMID: 36282455)
Blood. 2009 Jul 9;114(2):346-56. (PMID: 19365081)
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13451-6. (PMID: 19666505)
Sci Rep. 2017 Jan 05;7:39710. (PMID: 28054583)
Immunobiology. 2002 Dec;206(5):502-13. (PMID: 12607725)
J Clin Immunol. 2021 Feb;41(2):362-373. (PMID: 33190167)
J Immunol. 2020 Oct 15;205(8):2016-2025. (PMID: 32907998)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Clin Exp Immunol. 2002 Sep;129(3):446-52. (PMID: 12197885)
Immunity. 2018 Oct 16;49(4):725-739.e6. (PMID: 30314758)
J Immunol. 1995 May 1;154(9):4341-50. (PMID: 7722292)
J Allergy Clin Immunol. 2012 Nov;130(5):1197-1198.e9. (PMID: 22819511)
J Immunol. 2010 Jun 15;184(12):7305-13. (PMID: 20495065)
J Clin Immunol. 2022 Aug;42(6):1254-1269. (PMID: 35589883)
Eur J Immunol. 2009 Apr;39(4):1066-77. (PMID: 19266486)
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890-3. (PMID: 1371884)
Allergol Immunopathol (Madr). 2015 Jan-Feb;43(1):81-7. (PMID: 24656623)
Blood. 2002 Mar 1;99(5):1544-51. (PMID: 11861266)
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10362-7. (PMID: 11504927)
J Immunol. 2015 Sep 1;195(5):1933-7. (PMID: 26297793)
Sci Adv. 2021 May 26;7(22):. (PMID: 34039612)
J Exp Med. 1994 May 1;179(5):1517-27. (PMID: 8163935)
J Allergy Clin Immunol. 2024 Sep;154(3):778-791.e9. (PMID: 38692308)
J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):38-59. (PMID: 26563668)
Cytokine Growth Factor Rev. 2016 Aug;30:87-93. (PMID: 26980675)
Immunobiology. 2010;215(1):81-7. (PMID: 19249119)
Biomolecules. 2023 Jun 11;13(6):. (PMID: 37371554)
Rheum Dis Clin North Am. 1998 Aug;24(3):629-39. (PMID: 9710891)
Clin Immunol. 1999 Sep;92(3):224-34. (PMID: 10479527)
Contributed Indexing: Keywords: B-cell differentiation; CD21low B cells; Common variable immunodeficiency (CVID); IL-10; Immune dysregulation; Survival; TbethighCD21low B cells; Type 1 inflammation
Substance Nomenclature: 130068-27-8 (Interleukin-10)
0 (Receptors, Complement 3d)
MKM3CA6LT1 (Interleukin-21)
0 (STAT3 Transcription Factor)
0 (Interleukins)
0 (IL10 protein, human)
Entry Date(s): Date Created: 20260815 Date Completed: 20260815 Latest Revision: 20260818
Update Code: 20260818
PubMed Central ID: PMC13477453
DOI: 10.1007/s10875-026-02058-2
PMID: 42603226
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1573-2592
DOI:10.1007/s10875-026-02058-2